Get notified when VYGR files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsVoyager Therapeutics reports Q4 and full year 2025 financial results
Filed March 9, 2026 · Period ending March 9, 2026 · ~1 min read
Key Changes
-
high
Company announced fourth quarter and full year 2025 financial results and corporate updates through press release on March 9, 2026.
Item 2.02 verify on EDGAR → -
medium
Financial figures and operational details are contained in the furnished press release (Exhibit 99.1), not in the 8-K body itself.
8-K: Exhibit 99.1 view on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (TRV 10-Q) is open in full — no account needed.
Partner
Trade VYGR commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 5, 2026 · How we verify